Cite
HARVARD Citation
Lambertini, M. et al. (2019). Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO (BIG 1‐06) and ALTTO (BIG 2‐06) trials. Cancer. 125 (2), pp. 307-316. [Online].